Список литературы

Поставить закладку

Friedman-Birnbaum R, Bergman R, Bitterman-Deutsch O, Weltfriend S, Lichtig C. Classic and iatrogenic Kaposi"s sarcoma. Histopathological patterns as related to clinical course. Am J Dermatopathol. 1993 Dec;15(6):523-7. PMID: 8311180.
PDQ® Adult Treatment Editorial Board. PDQ Kaposi Sarcoma Treatment. Bethesda, MD: National Cancer Institute.
Mbulaiteye SM, Engels EA. Kaposi"s sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer. 2006 Dec 1;119(11):2685-91.
Stallone G., Schena A., Infante B. et al. Sirolimus for Kaposi"s sarcoma in renal-transplant recipients. N Engl J Med. 2005; 352 (13): 1317–1323.
Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, et al. Management of AIDS-related Kaposi"s sarcoma. Lancet Oncol. Feb 2008;8(2):167-76.
Kutlubay Z, Kucuktas M, Yardimci G, et al. Evaluation of effectiveness of cryotherapy on the treatment of cutaneous Kaposi"s sarcoma. Dermatol Surg. 2013 Oct;39(10):1502-6.
Tsao MN, Sinclair E, Assaad D, et al.: Radiation therapy for the treatment of skin Kaposi sarcoma. Ann Palliat Med 5 (4): 298-302, 2016.
Régnier-Rosencher E, Guillot B, Dupin N: Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol 68 (2): 313-31, 2013.
E Odyakmaz Demirsoy, D Bayramgürler, Ç Çağlayan, N Bilen, A Şikar Aktürk, R Kıran Imiquimod 5% Cream Versus Cryotherapy in Classic Kaposi Sarcoma/ Journal of cutaneous medicine and surgery, 2019.
Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, et al. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. Aug 15 2010;116(16):3969-77.
Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009 Jun 4;4(6):e5790. doi: 10.1371/journal.pone.0005790. PMID: 19495419; PMCID: PMC2686174.
Hu S.C., Ke C.L., Lee C.H. et al. // J. Eur. Acad. Dermatol. Venerol. – 2009. – Vol. 23, N 10. – P. 1128– 1132 Soft Tissue and Bone Tumours WHO Classification of Tumours, 5th Edition, Volume 3, WHO Classification of Tumours Editorial Board.
Soft Tissue and Bone TumoursWHO Classification of Tumours, 5th Edition, Volume 3, WHO Classification of Tumours Editorial Board,ISBN - 978-92-832-4502-5, Cree, Ian A. (Editorial Board Chair).
Lebbe C, Garbe C, Stratigos AJ, Harwood C, Peris K, Marmol VD, Malvehy J, Zalaudek I, Hoeller C, Dummer R, Forsea AM, Kandolf-Sekulovic L, Olah J, Arenberger P, Bylaite-Bucinskiene M, Vieira R, Middleton M, Levy A, Eggermont AM, Battistella M, Spano JP, Grob JJ, Pages C; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Kaposi"s sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer. 2019 Jun;114:117-127. doi: 10.1016/j.ejca.2018.12.036. Epub 2019 May 13. PMID: 31096150.
Erin Reid, Gita Suneja et al, NCCN Clinical Practice Guidelines in Oncology, Version 3.2020 AIDS-Related Kaposi Sarcoma.
Krown SE, Testa MA, Huang J. AIDS-related Kaposi’s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 1997;15:3085e92.
Brenner B, Weissmann-Brenner A, Rakowsky E, Weltfriend S, Fenig E, Friedman-Birnbaum R, et al. Classical Kaposi sarcoma: prognostic factor analysis of 248 patients. Cancer 2002;95:1982e7.
Zaraa I, Labbene I, El Guellali N, Ben Alaya N, Mokni M, Ben Osman A. [Kaposi’s sarcoma: epidemiological, clinical, anatomopathological and therapeutic features in 75 patients]. Tunis Med 2012;90:116e21.
Bower M, Dalla Pria A, Coyle C, Andrews E, Tittle V, Dhoot S, et al. Prospective stage-stratified approach to AIDS-related Kaposi’s sarcoma. J Clin Oncol 2014;32:409e14.
Nasti G, Martellotta F, Berretta M, Mena M, Fasan M, Di Perri G, et al. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 2003; 98:2440e6.
Frances C. Kaposi’s sarcoma after renal transplantation. Nephrol Dial Transplant 1998;13:2768e73.
Pellet C, Kerob D, Dupuy A, Carmagnat MV, Mourah S, Podgorniak MP, et al. Kaposi’s sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi’s sarcoma. J Invest Dermatol 2006;126:621e7.
Jakob L, Metzler G, Chen KM, Garbe C. Non-AIDS associated Kaposi’s sarcoma: clinical features and treatment outcome. PLoS One 2011;6:e18397
Erin Reid, Gita Suneja et al, NCCN Clinical Practice Guidelines in Oncology, Version 1.2021 AIDS-Related Kaposi Sarcoma.
Koon HB, Krown SE, Lee JY, Honda K, Rapisuwon S, Wang Z, Aboulafia D, Reid EG, Rudek MA, Dezube BJ, Noy A. Phase II trial of imatinib in AIDS-associated Kaposi"s sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol. 2014 Feb 10;32(5):402-8. doi: 10.1200/JCO.2012.48.6365. Epub 2013 Dec 30. PMID: 24378417; PMCID: PMC3912327.
Strother RM, Gregory KM, Pastakia SD, Were P, Tenge C, Busakhala N, Jakait B, Schellhase EM, Rosmarin AG, Loehrer PJ. Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi"s sarcoma in western Kenya. Oncology. 2010;78(1):5-11. doi: 10.1159/000292356. Epub 2010 Mar 6. PMID: 20215784
Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Crysler OV, Gupta N, Gustafson C, Hall A, Johung KL, Klopp A, LaCasce AS, Lin C, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Ratner L, Rizza S, Rudek MA, Sanchez J, Taylor J, Tomlinson B, Wang CJ, Yendamuri S, Dwyer MA; CGC; Freedman-Cass DA. AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Feb;17(2):171-189. doi: 10.6004/jnccn.2019.0008. PMID: 30787130.
Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin JN, Orem J, Godfrey C, Hoagland B, Mwelase N, Langat D, Nyirenda M, MacRae J, Borok M, Samaneka W, Moses A, Mngqbisa R, Busakhala N, Martínez-Maza O, Ambinder R, Dittmer DP, Nokta M, Campbell TB; A5264/AMC-067 REACT-KS Team. As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis. 2018 Jul 2;67(2):251-260. doi: 10.1093/cid/ciy044. PMID: 29365083; PMCID: PMC6030807.
Cao W, Vyboh K, Routy B, Chababi-Atallah M, Lemire B, Routy JP. Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review. Curr Oncol. 2015 Oct;22(5):e395-9. doi: 10.3747/co.22.2635. PMID: 26628884; PMCID: PMC4608417.
Koon HB, Krown SE, Lee JY, Honda K, Rapisuwon S, Wang Z, Aboulafia D, Reid EG, Rudek MA, Dezube BJ, Noy A. Phase II trial of imatinib in AIDS-associated Kaposi"s sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol. 2014 Feb 10;32(5):402-8. doi: 10.1200/JCO.2012.48.6365. Epub 2013 Dec 30. PMID: 24378417; PMCID: PMC3912327.
Stelzer KJ, Griffin TW. A randomized prospective trial of radiation therapy for AIDS-associated Kaposi’s sarcoma. Int J Radiat Oncol Biol Phys 1993;27:1057e61.
Singh NB, Lakier RH, Donde B. Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma–a prospective randomized trial. Radiother Oncol 2008;88:211e6.
Harrison M, Harrington KJ, Tomlinson DR, Stewart JS. Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi’s sarcoma. Radiother Oncol 1998;46:23e8.
Kigula-Mugambe JB, Kavuma A. Epidemic and endemic Kaposi’s sarcoma: a comparison of outcomes and survival after radiotherapy. Radiother Oncol 2005;76:59e62.
Yildiz F, Genc M, Akyurek S, Cengiz M, Ozyar E, Selek U, et al. Radiotherapy in the management of Kaposi’s sarcoma: comparison of 8 Gy versus 6 Gy. J Natl Med Assoc 2006;98:1136e9.
Caccialanza M, Marca S, Piccinno R, Eulisse G. Radiotherapy of classic and human immunodeficiency virus-related Kaposi’s sarcoma: results in 1482 lesions. J Eur Acad Dermatol Venereol 2008;22:297e302.Hamilton CR, Cummings BJ, Harwood AR. Radiotherapy of Kaposi’s sarcoma. Int J Radiat Oncol Biol Phys 1986;12:1931e5.
Hamilton CR, Cummings BJ, Harwood AR. Radiotherapy of Kaposi’s sarcoma. Int J Radiat Oncol Biol Phys 1986;12:1931e5.
Weshler Z, Loewinger E, Loewenthal E, Levinson R, Fuks Z. Megavoltage radiotherapy using water bolus in the treatment of Kaposi’s sarcoma. Int J Radiat Oncol Biol Phys 1986;12:2029e32.
Ertürk Yılmaz T, Akay BN, Okçu Heper A. Dermoscopic findings of Kaposi sarcoma and dermatopathological correlations. Australas J Dermatol. 2020 Feb;61(1):e46-e53. doi: 10.1111/ajd.13150. Epub 2019 Sep 8. PMID: 31495914.
Т.Фицпатрик,Р.Джонсон,К.Вулф Дерматология атлас-справочник 1999 .
А.А.Кубанова, В.И.Кисина Рациональная фармокотерапия заболеваний кожи и инфекций,передаваемых половым путем 2005
Казанцева К.В., Молочков А.В., Молочков В.А., Сухова Т.Е., Прокофьев А.А., Каприн А.Д., Галкин В.Н., Иванов С.А., Каплан М.А., Романко Ю.С., Попучиев В.В. Саркома Капоши: патогенез, клиника, диагностика и современные принципы лечения // Российский журнал кожных и венерических болезней. 2015. №1.
Karass M, Grossniklaus E, Seoud T, Jain S, Goldstein DA. Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable Condition. Oncologist. 2017 May;22(5):623-625. doi: 10.1634/theoncologist.2016-0237. Epub 2017 Apr 19. PMID: 28424322; PMCID: PMC5423516.
Hoffmann C, Sabranski M, Esser S. HIV-Associated Kaposi"s Sarcoma. Oncol Res Treat. 2017;40(3):94-98. doi: 10.1159/000455971. Epub 2017 Feb 9. PMID: 28259888.
В.В.Рассохин, А.Р.Крестьянинов Саркома Капоши. Диагностика и лечение//Практическая онкология, Т. 13, №2 – 2012
Zidan J, Robenstein W, Abzah A, Taman S. Treatment of Kaposi"s sarcoma with vinblastine in patients with disseminated dermal disease. Isr Med Assoc J. 2001 Apr;3(4):251-3. PMID: 11344835.
Goncalves PH, Ziegelbauer J, Uldrick TS, Yarchoan R. Kaposi sarcoma herpesvirus-associated cancers and related diseases. Curr Opin HIV AIDS. 2017 Jan;12(1):47-56. doi: 10.1097/COH.0000000000000330. PMID: 27662501; PMCID: PMC6311702.
Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Peer CJ, Bevans M, Sereti I, Maldarelli F, Whitby D, Marshall V, Goncalves PH, Khetani V, Figg WD, Steinberg SM, Zeldis JB, Yarchoan R. Pomalidomide for Symptomatic Kaposi"s Sarcoma in People With and Without HIV Infection: A Phase I/II Study. J Clin Oncol. 2016 Dec;34(34):4125-4131. doi: 10.1200/JCO.2016.69.3812. Epub 2016 Oct 31. Erratum in: J Clin Oncol. 2018 Jul 1;36(19):2008. doi: 10.1200/JCO.2018.79.3158. PMID: 27863194; PMCID: PMC5477825.
Казанцева К.В., Молочков А.В., Молочков В.А., Сухова Т.Е., Прокофьев А.А., Каприн А.Д., Галкин В.Н., Иванов С.А., Каплан М.А., Романко Ю.С., Попучиев В.В. Саркома Капоши: патогенез, клиника, диагностика и современные принципы лечения// РОССИЙСКИЙ ЖУРНАЛ КОЖНЫХ И ВЕНЕРИЧЕСКИХ БОЛЕЗНЕЙ No 1, 2015.
Карташова М. Г. Фотодинамическая терапия в лечении идиопатического типа саркомы Капоши// Дерматология №2 2009.
Карташова М. Г Современные подходы к диагностике и лечению идиопатического типа саркомы Капоши //Дерматология 2 — 2008.
Moray G, Başaran O, Yağmurdur MC, Emiroğlu R, Bilgin N, Haberal M. Immunosuppressive therapy and Kaposi"s sarcoma after kidney transplantation. Transplant Proc. 2004 Jan-Feb;36(1):168-70. doi: 10.1016/j.transproceed.2003.11.016. PMID: 15013336.
Htet KZ, Waul MA, Leslie KS. Topical treatments for Kaposi sarcoma: A systematic review. Skin Health Dis. 2022 Apr 8;2(2):e107. doi: 10.1002/ski2.107. PMID: 35677916; PMCID: PMC9168015.
Erin Reid et al. NCCN Guidelines Version 1.2021, Kaposi Sarcoma, 2/12/21
Brambilla L, Labianca R, Boneschi V, Fossati S, Dallavalle G, Finzi AF, Luporini G. Mediterranean Kaposi"s sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine. Cancer. 1994 Nov 15;74(10):2873-8. doi: 10.1002/1097-0142(19941115)74:10<2873::aid-cncr2820741021>3.0.co;2-1. PMID: 7954250.
Brambilla L, Boneschi V, Fossati S, Melotti E, Clerici M. Oral etoposide for Kaposi"s Mediterranean sarcoma. Dermatologica. 1988;177(6):365-9. doi: 10.1159/000248608. PMID: 2466707.
Tas F, Sen F, Keskin S, Kilic L. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi"s sarcoma (CKS): a single-arm trial (oral etoposide in CKS). J Eur Acad Dermatol Venereol. 2013 Jun;27(6):789-92. doi: 10.1111/j.1468-3083.2011.04404.x. Epub 2011 Dec 20. PMID: 22188463.
Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., Carbone P. P. Toxicity and response criteria of the Eastern Cooperative Oncology Group // Am J Clin Oncol. ‒ 1982. ‒ T. 5, № 6. ‒ C. 649-55.
Karnofsky D. A., Burchenal J. H. The clinical evaluation of chemotherapeutic agents in cancer // Evaluation of chemotherapeutic agents / MacLeod C. ‒ New York: Columbia University Press, 1949. ‒ C. 191-205
M. Silveira Vilbert, I. Hirsch, E.C. Koch, T. Pimentel Muniz, D. Pinheiro Xavier et al. Treatment of Kaposi sarcoma with immune-checkpoint inhibitors: A systematic review and single-arm meta-analysis. 775P, Vol.33, Suppl. 7, S895, Sep 2022.I:https://doi.org/10.1016/j.annonc.2022.07.901
Delyon J, Biard L, Renaud M, Resche-Rigon M, et al. PD-1 blockade with pembrolizumab in classic or endemic Kaposi"s sarcoma: a multicentre, single-arm, phase 2 study. Lancet Oncol. 2022 Apr;23(4):491-500. doi: 10.1016/S1470-2045(22)00097-3. Epub 2022 Mar 10. PMID: 35279271.
Lolli I, Valentini AM, Ricci AD, Armentano R. Anaplastic Classic Kaposi Sarcoma: PD-L1 Expression and Response to Immunotherapy: A Case Report and Review of the Literature. J Natl Compr Canc Netw. 2023 Apr 7;21(5):442-448.e2. doi: 10.6004/jnccn.2022.7091. PMID: 37028800.
Silver JK, Baima J: Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil 2013, 92(8):715-727.
Nilsson H, Angeras U, Bock D, Borjesson M, Onerup A, Fagevik Olsen M, Gellerstedt M, Haglind E, Angenete E: Is preoperative physical activity related to post-surgery recovery? A cohort study of patients with breast cancer. BMJ open 2016, 6(1):e007997.
Siegel GW, Biermann JS, Chugh R, Jacobson JA, Lucas D, Feng M, Chang AC, Smith SR, Wong SL, Hasen J: The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework. J Multidiscip Healthc 2015, 8:109-115.
Shehadeh A, El Dahleh M, Salem A, Sarhan Y, Sultan I, Henshaw RM, Aboulafia AJ: Standardization of rehabilitation after limb salvage surgery for sarcomas improves patients" outcome. Hematol Oncol Stem Cell Ther 2013, 6(3-4):105-111.
Cox CL, Montgomery M, Oeffinger KC, Leisenring W, Zeltzer L, Whitton JA, Mertens AC, Hudson MM, Robison LL: Promoting physical activity in childhood cancer survivors: results from the Childhood Cancer Survivor Study. Cancer 2009, 115(3):642-654.
Oren R, Zagury Al, Katzir O, Kollender Y, Meller I: Musculoskeletal Cancer Surgery. In., edn. Edited by Malawer. Dordrecht: Springer; 2013: 583-593.
Segal R, Zwaal C, Green E, Tomasone JR, Loblaw A, Petrella T, Exercise for People with Cancer Guideline Development G: Exercise for people with cancer: a systematic review. Curr Oncol 2017, 24(4):e290-e315.
Boyd C, Crawford C, Paat CF, Price A, Xenakis L, Zhang W, Evidence for Massage Therapy Working G: The Impact of Massage Therapy on Function in Pain Populations-A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Part II, Cancer Pain Populations. Pain Med 2016, 17(8):1553-1568.
O"Mahony D, Gandjbakche A, Hassan M, Vogel A, Yarchoan R. Imaging techniques for Kaposi"s sarcoma. J HIV Ther. 2008 Sep;13(3):65-71. PMID: 19039297; PMCID: PMC2600536.
Restrepo CS, Ocazionez D. Kaposi"s sarcoma: imaging overview. Semin Ultrasound CT MR. 2011 Oct;32(5):456-69. doi: 10.1053/j.sult.2011.03.007. PMID: 21963166.
Addula D, Das CJ, Kundra V. Imaging of Kaposi sarcoma. Abdom Radiol (NY). 2021 Nov;46(11):5297-5306. doi: 10.1007/s00261-021-03205-6. Epub 2021 Jul 13. PMID: 34255129; PMCID: PMC8502139.
Weprin L, Zollinger R, Clausen K, Thomas FB. Kaposi"s sarcoma: endoscopic observations of gastric and colon involvement. J Clin Gastroenterol. 1982 Aug;4(4):357-60. PMID: 7119413.
Aliaga Ramos J, Cedrón Cheng H, Pinto Valdivia J. Clinical and endoscopic findings of patients with cutaneous Kaposi sarcomaand gastrointestinal involvement. Experience in a single center of Lima-Peruin the last 3 years. Rev Gastroenterol Peru. 2019 Apr-Jun;39(2):123-126. English. PMID: 31333227.
Carmo J, Marques SC, Bispo M, Pinto D, Chagas C. Clinical and Endoscopic Features of Gastrointestinal Kaposi Sarcoma: A Single-Center Portuguese Experience over the Last Decade. GE Port J Gastroenterol. 2017 Sep;24(5):219-226. doi: 10.1159/000461592. Epub 2017 Apr 11. PMID: 29255756; PMCID: PMC5729958.
Erin Reid, Gita Suneja et al. NCCN Guidelines Version 1.2024 Kaposi Sarcoma. https://www.nccn.org/professionals/physician_gls/pdf/kaposi.pdf
Célestin Schartz NE, Chevret S, Paz C, Kerob D, Verola O, Morel P, Lebbé C. Imiquimod 5% cream for treatment of HIV-negative Kaposi"s sarcoma skin lesions: A phase I to II, open-label trial in 17 patients. J Am Acad Dermatol. 2008 Apr;58(4):585-91. doi: 10.1016/j.jaad.2007.11.005. Epub 2008 Feb 20. PMID: 18068265.
Benomar S, Boutayeb S, Benzekri L, Errihani H, Hassam B. Kaposi"s sarcoma responding to topical imiquimod 5% cream: a case report. Cases J. 2009 Sep 17;2:7092. doi: 10.1186/1757-1626-0002-0000007092. PMID: 20181188; PMCID: PMC2827081.
Brambilla L, Labianca R, Ferrucci SM, Taglioni M, Boneschi V. Treatment of classical Kaposi"s sarcoma with gemcitabine. Dermatology. 2001;202(2):119-22. doi: 10.1159/000051610. PMID: 11306832.
Badalamenti G, Incorvaia L, Algeri L, Bonasera A, Dimino A, Scalia R, Cucinella A, Madonia G, Pomi FL, Galvano A, Gristina V, Toia F, Cordova A, Bazan V, Russo A. Safety and effectiveness of gemcitabine for the treatment of classic Kaposi"s sarcoma without visceral involvement. Ther Adv Med Oncol. 2022 Mar 26;14:17588359221086829. doi: 10.1177/17588359221086829. PMID: 35356263; PMCID: PMC8958699.
Costa da Cunha CS, Lebbe C, Rybojad M, Agbalika F, Ferchal F, Rabian C, Vignon-Pennamen MD, Calvo F, Morel P. Long-term follow-up of non-HIV Kaposi"s sarcoma treated with low-dose recombinant interferon alfa-2b. Arch Dermatol. 1996 Mar;132(3):285-90. doi: 10.1001/archderm.132.3.285. PMID: 8607632.
Curatolo P, Careri R, Simioni A, Campana LG. Cryotherapy, Imiquimod, and Electrochemotherapy Are Effective Options for Kaposi Sarcoma: A Call for Standardization to Allow for Comparisons and Informed Decisions. J Cutan Med Surg. 2020 Mar/Apr;24(2):218-219. doi: 10.1177/1203475419893302. PMID: 32208013.
Chao S, Lee Y, Tsao C. Treatment of classical type Kaposi"s sarcoma with paclitaxel. Anticancer Res 21: 571-574, 200.
Engin H, Celik I. Treatment of classical Kaposi"s sarcoma with visceral involvement by weekly paclitaxel. Clin Oncol (R Coll Radiol). 2002 Apr;14(2):178. doi: 10.1053/clon.2002.0058. PMID: 12069127.
Paksoy N, Khanmammadov N, Doğan İ, Ferhatoğlu F, Ahmed MA, Karaman S, Aydiner A. Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study. Medicine (Baltimore). 2023 Feb 3;102(5):e32866. doi: 10.1097/MD.0000000000032866. PMID: 36749246; PMCID: PMC9901949.